scispace - formally typeset
R

Rosario Samanin

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  270
Citations -  13496

Rosario Samanin is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Serotonin & Dopamine. The author has an hindex of 65, co-authored 270 publications receiving 13375 citations. Previous affiliations of Rosario Samanin include China Pharmaceutical University.

Papers
More filters
Journal ArticleDOI

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

TL;DR: The results suggest that the ability of serotonin uptake inhibitors to enhance the extracellular concentrations of serotonin in the dorsal raphe attenuates the drug's effect in the frontal cortex.
Journal Article

The mechanism of action of fenfluramine.

TL;DR: For the remainder of the population whose hyperlipidaemia is polygenically determined, the liability to coronary heart disease might be substantially reduced by simple and appropriate environmental measures aimed at reducing the total liability.
Journal ArticleDOI

Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference

TL;DR: The results suggest that dopaminergic D1 (but not D2) and glutamatergic NMDA and NMDA receptors are involved in the primary rewarding properties of cocaine (as assessed by the establishment of CPP) whereas the AMPA/kainate receptors are important only for the behaviour elicited by the stimuli previously associated with the drug action (CPP expression).
Journal ArticleDOI

Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance

TL;DR: Changes in P-gp mRNA levels occur in limbic areas after both acute and chronic epileptic activity, suggesting that seizure-induced mdr mRNA expression contributes to MDR in epilepsy.
Journal ArticleDOI

m-Chlorophenylpiperazine: A central serotonin agonist causing powerful anorexia in rats

TL;DR: The data suggest that the decrease of food intake induced by metachlorophenylpiperazine depends on its ability to act as a serotonin agonist in the brain, which could prove an important tool for studies aimed at elucidating the functional role of serotonin in the central nervous system.